Lackner Mark
Zentalis Pharmaceuticals, Inc. · Chief Scientific Officer
Lackner Mark is listed in public filings as officer: Chief Scientific Officer. This Lackner Mark insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Zentalis Pharmaceuticals, Inc. (ZNTL). Investors use Lackner Mark's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $210k124.7k shares | Grant / ExerciseFeb 3, 2025 | $209.5K124.7k shares | $1.68 | -- | |
| --527.2k shares | Grant / ExerciseFeb 3, 2025 | Disclosure amount unavailable335.9k shares | -- | -- | |
| $878k512.9k shares | SellFeb 3, 2025 | $24.6K14.4k shares | $1.71 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $597k191.3k shares | SellJan 2, 2025 | $13.8K4.4k shares | $3.12 | -- |